Exogenous Ketones
Exogenous Ketones scored 5.9 / 10 (👍 Worth trying) on the BioHarmony scale as a Substance → Exogenous Metabolite.
Exogenous ketones are supplements (ketone esters, ketone salts, or 1,3-butanediol) that raise blood beta-hydroxybutyrate within minutes without diet change. The honest read: a 2022 meta-analysis of 8 studies found no endurance-performance benefit (Hedges g=0.14, p=0.42, per Brooks et al.), while real but early signals exist for heart-failure hemodynamics (Nielsen et al. 2019) and training-overload tolerance.
What is Exogenous Ketones?
Exogenous ketones are supplements that raise the blood ketone beta-hydroxybutyrate (BHB) within 30 to 60 minutes, without any change in diet. They are bought to get the blood chemistry of a fasted or ketogenic state on demand, before a workout, a long meeting, or a meal. The honest verdict is that they do something real and fast, but the most-marketed use, raw endurance performance, is the part the evidence does not support: Brooks et al. 2022 pooled 8 studies and 80 participants and found no significant benefit (Hedges g=0.14, p=0.42). The genuinely interesting signals are elsewhere: hemodynamic support in heart failure and training-overload tolerance.
There are three forms, and they differ a lot. The ketone monoester is the strongest and most studied; it reliably pushes blood ketones to 1 to 5 mM, but it tastes harsh and costs roughly a dollar per gram. Ketone salts bind BHB to sodium, calcium, or magnesium, which makes them cheaper and easier to drink but caps the dose and adds a mineral load. 1,3-butanediol is a precursor your body converts to BHB through the same enzymes that process alcohol, so it can feel mildly intoxicating. BHB then works as both an alternative fuel for the muscle, heart, and brain and as a signaling molecule that influences inflammation and appetite.
Terminology
The biggest source of confusion with exogenous ketones is conflation: the impressive evidence for "ketosis" usually comes from diets or medium-chain triglycerides, not from the drink in the bottle. These are the terms that decide whether a claim actually applies to the supplement.
- BHB (beta-hydroxybutyrate): The main ketone body these supplements deliver. Used as fuel and as a signaling molecule.
- Ketone monoester: BHB chemically bonded to a precursor alcohol. The strongest, most-studied, and most expensive form.
- Ketone salts: BHB bound to minerals (sodium, calcium, magnesium). Cheaper and more palatable, but the mineral load caps the usable dose.
- 1,3-butanediol: A ketone precursor metabolized to BHB via alcohol-dehydrogenase enzymes. Can produce a mild alcohol-like effect.
- MCT (medium-chain triglycerides): A FAT, not an exogenous ketone. The body slowly converts some MCT to ketones. Much of the "ketones for the brain" evidence is actually MCT, and should not be credited to ketone esters.
- Ketogenic diet: A high-fat, very-low-carb diet that produces ketosis through food. The epilepsy and most cognition evidence belongs here, not to the supplement.
- GRAS: Generally Recognized As Safe, a US FDA food-ingredient status. The D-BHB ester holds GRAS notice GRN 515.
- HFrEF: Heart Failure with reduced Ejection Fraction, the population in the strongest cardiac trials.
- AUC: Area Under the Curve, used here for total blood-glucose exposure after a meal or glucose load.
How do you take Exogenous Ketones?
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
View 3 routes and 3 protocols
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral (ketone monoester) | D-BHB monoester drink | 10 to 25 g BHB per serving | 10 to 30 g BHB |
| Oral (ketone salts) | BHB bound to sodium, calcium, magnesium | 7 to 12 g BHB per serving | 7 to 16 g BHB |
| Oral (1,3-butanediol) | Precursor diol, often in blends | Not well standardized | 10 to 25 g |
Protocols
Pre-task acute dose Mixed
- Dose
- Ester 10 to 25 g BHB
- Frequency
- As needed before the target event
- Duration
- Single use
Take 30 to 60 minutes before exercise, a cognitive task under fatigue, or a meal for appetite blunting. Effect is gone within hours.
Training-overload support Clinical
- Dose
- About 25 g ester post-exercise plus pre-sleep
- Frequency
- Daily during a heavy training block
- Duration
- 2 to 3 week overload phase
Modeled on the Leuven overreaching protocol ([Poffe 2019](https://pubmed.ncbi.nlm.nih.gov/31039280/)). Expensive at this frequency.
Heart-failure hemodynamic support (clinical only) Clinical
- Dose
- Per-study oral or infused BHB
- Frequency
- Investigational
- Duration
- Acute to 2 weeks in trials
Only under cardiology supervision inside a trial or specialist setting. Not a self-directed protocol.
How this score is calculated →
What are the benefits of Exogenous Ketones?
Upside contribution: 1.80
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 2.6 | 0.650 | |
| Breadth | 15% | 3.0 | 0.450 | |
| Evidence | 25% | 2.8 | 0.700 | |
| Speed | 10% | 4.2 | 0.420 | |
| Durability | 10% | 1.6 | 0.160 | |
| Bioindividuality | 15% | 2.8 | 0.420 | |
| Total | 2.800 |
Upside Rationale
The upside of exogenous ketones is narrow and fast rather than broad and deep. The strongest, most replicated benefit is not what they are sold for: training-overload tolerance (Poffe et al. 2019, about 15 percent higher week-3 training load) and acute hemodynamic support in heart failure (Nielsen et al. 2019, cardiac output up about 2.0 L per minute). The hard boundary condition is durability: every effect is acute and gone within hours, so there is no accumulating benefit from a single dose.
Efficacy (2.6/5.0): The single strongest, best-replicated real-world finding is negative for the marketed use: Brooks et al. 2022, a meta-analysis of 8 studies and 80 participants, found no endurance benefit (Hedges g=0.14, 95% CI -0.20 to 0.47, p=0.42), and Leckey et al. 2017 found a roughly 2 percent impairment in 10 elite cyclists. Where efficacy is real, it is modest and acute: glucose AUC down about 17 percent (Myette-Cote et al. 2018, n=20), acute appetite suppression in healthy adults, and a genuine but early heart-failure hemodynamic effect. The magnitude that healthy buyers most want is the magnitude that is missing.
Breadth of Benefits (3.0/5.0): Exogenous ketones touch several systems, which lifts breadth above efficacy. Cardiac: improved output in failing hearts (Nielsen et al. 2019). Training physiology: blunted overreaching and raised EPO (Poffe et al. 2019). Metabolic: acute glucose lowering and appetite suppression. Brain: small acute cognitive effects under fatigue (Evans and Egan 2018). The scope boundary is that each of these is modest or early, and the headline endurance and dementia claims do not hold for the supplement form, so breadth reflects reach rather than depth.
Evidence Quality (2.8/5.0): Real human RCTs exist, which is more than many supplements can say, but the body is mixed-to-null on the core use and thin everywhere it is promising. The performance literature has a clean meta-analysis showing no effect (Brooks et al. 2022), and the lone strong positive (Cox et al. 2016) rested on 8 athletes from the patent-holding lab, a sponsor-conflict signal worth a modest trim. The cardiac and recovery signals are exciting but come from single research groups with n=8 to 24 and no hard-outcome trials. A persistent integrity problem is conflation: the strong Alzheimer's and epilepsy evidence is MCT or diet, not ketone esters, and should not be borrowed.
Speed of Onset (4.2/5.0): This is the standout dimension. Blood ketones rise to 1 to 5 mM within 30 to 60 minutes of a dose, regardless of diet, per the kinetics in Clarke et al. 2012. The acute glucose and appetite effects appear in the same single-session window. If you want the metabolic state of fasting or a ketogenic diet without the days of adaptation those require, this is the fastest available route. Speed is the one thing exogenous ketones unambiguously deliver.
Durability (1.6/5.0): Durability is the weakest dimension and a structural one. BHB has a half-life of 0.8 to 3.1 hours and clears by about 4 hours (Clarke et al. 2012), so a single dose produces no lasting adaptation. There is no carryover, no training effect on the ketone system, and the 28-day studies are safety trials, not adaptation studies. Any benefit must be re-purchased and re-timed for each use, which compounds the cost problem.
Bioindividuality Upside (2.8/5.0): Response varies by both person and goal. Heart-failure patients show a clear hemodynamic response (Nielsen et al. 2019); endurance athletes mostly do not benefit and some are slowed by GI distress (Leckey et al. 2017). GI tolerance is itself a strong responder split: some people drink an ester with no issue, others get nausea or diarrhea at the same dose. The best-matched user is defined by goal (clinical hemodynamic support, training-overload tolerance, acute appetite or glucose blunting), not by a general trait.
What are the risks & downsides of Exogenous Ketones?
Downside contribution: 1.10 (safety risks weighted extra)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety | 30% | 1.8 | 0.540 | |
| Side effects | 15% | 2.8 | 0.420 | |
| Cost | 5% | 4.3 | 0.215 | |
| Effort | 5% | 2.2 | 0.110 | |
| Opportunity | 5% | 2.6 | 0.130 | |
| Dependency | 15% | 1.2 | 0.180 | |
| Reversibility | 25% | 1.1 | 0.275 | |
| Total | 1.870 | |||
| Harm subtotal × 1.4 | 1.981 | |||
| Opportunity subtotal × 1.0 | 0.455 | |||
| Combined downside | 2.436 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 1.096 |
Downside Rationale
The dominant downside is not danger, it is value: exogenous ketones are intrinsically safe but expensive, acute-only, and most exposed to opportunity cost for the healthy buyer chasing performance who would do better with cheaper, proven options. The risk is mild and concentrated in tolerability (GI distress from esters, sodium load from salts) rather than in any catastrophic or lasting harm. Everything reverses cleanly when you stop.
Safety Risk (1.8/5.0): Exogenous ketones have no demonstrated catastrophic intrinsic risk at normal doses. A 28-day study, Soto-Mota et al. 2019, found no adverse effect on any blood, urine, or physical parameter, and the kinetics work of Clarke et al. 2012 (n=54) reported only dose-dependent GI effects with no serious events. The blood ketone levels reached (1 to 5 mM) are far below the 15 to 25 mM range of dangerous diabetic ketoacidosis. The two real cautions are population-specific, not intrinsic: people on glucose-lowering medication should account for additive glucose lowering, and people with type 1 diabetes should know that exogenous ketones can confound the ketone readings used to detect ketoacidosis. These are Verdict caveats, not a high-risk floor.
Side Effect Profile (2.8/5.0): Tolerability is the main day-to-day drawback. Ketone esters taste strongly unpleasant and cause nausea, reflux, or diarrhea at higher doses, and GI distress was the mechanism behind the performance impairment in Leckey et al. 2017. Ketone salts shift the problem: the bound sodium, calcium, and magnesium add a meaningful mineral load that both caps the dose and tends to cause more GI upset per gram of BHB. 1,3-butanediol can produce a mild alcohol-like sensation because it shares ethanol's metabolic enzymes. None of this is dangerous, but it is common enough to be a real adherence barrier.
Financial Cost (4.3/5.0): This is the second-worst dimension. Ketone esters run roughly a dollar per gram, so a single 25 to 30 g performance dose costs about $30, and the acute-only pharmacology means there is no way to amortize that, every use is a fresh purchase. Salts and 1,3-butanediol are cheaper but deliver weaker, dose-capped ketosis. For a daily training-overload protocol the monthly cost is steep, and for most healthy users the value per dollar is poor relative to the modest, often null, effect.
Time/Effort Burden (2.2/5.0): The mechanics are simple, you drink it, but timing matters and the taste of the ester is a genuine friction point that some users cannot get past. There is no cycling, preparation, or complex protocol, which keeps effort low.
Opportunity Cost (2.6/5.0): For the healthy performance buyer, opportunity cost is real. The money and attention spent chasing an endurance benefit that the meta-analysis says is not there (Brooks et al. 2022) would be better spent on training, sleep, carbohydrate periodization, or proven aids like caffeine and creatine, all far cheaper. There is also a direct interference risk: in some athletes the GI distress slows them down. The opportunity cost is lower for the narrow clinical or training-overload use where the signal is real.
Dependency/Withdrawal (1.2/5.0): There is no dependency, tolerance, or withdrawal syndrome. The body makes ketones endogenously, and intermittent exogenous dosing does not create a need for more.
Reversibility (1.1/5.0): Fully and immediately reversible. Stop taking it and blood ketones return to baseline within hours, with no taper, no rebound, and no lasting change. This is the cleanest dimension in the profile.
Is Exogenous Ketones worth it?
Exogenous ketones earn a 5.9 / 10, worth trying, but only for a person whose goal matches the narrow slice of evidence that is actually real. They are fast, intrinsically safe, and fully reversible, and there are genuine signals in heart-failure hemodynamics (Nielsen et al. 2019) and training-overload tolerance (Poffe et al. 2019). The score is held down, not by danger, but by the combination of a null endurance literature (Brooks et al. 2022), a high price with no way to amortize it, and an acute-only effect that produces no lasting adaptation. The tier is justified because the upside is real but narrow and the main cost is value, not harm.
✅ Best for: Heart-failure patients exploring hemodynamic support under cardiology supervision inside a trial or specialist setting, where the strongest signal lives. Endurance athletes in a heavy training-overload block who want better training tolerance, not race-day speed. People who want a fast, controllable acute appetite or blood-glucose blunting tool before a meal, with realistic expectations. Biohackers who value reaching a ketotic blood state in under an hour without days of dietary adaptation. Anyone who has read the meta-analysis and wants to self-experiment with clear endpoints and a stop rule, accepting the cost.
❌ Avoid if: You are a healthy athlete expecting an endurance-performance edge, because the pooled evidence shows none and one trial showed impairment. You want a brain or Alzheimer's intervention, since that evidence is medium-chain triglycerides and ketogenic diets, not ketone esters. You take insulin or sulfonylureas without accounting for additive glucose lowering, or you have type 1 diabetes and rely on ketone readings to detect ketoacidosis. You are price-sensitive, since esters cost about $30 per dose with no carryover. You cannot tolerate the taste or the GI effects, which are common enough to derail consistent use.
What is Exogenous Ketones best for?
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
Cardiovascular: 6.0/10
Score: 6.0/10The most interesting therapeutic-adjacent signal. Nielsen 2019 gave acute 3-hydroxybutyrate to 16 chronic heart-failure patients and saw cardiac output rise about 2.0 L per minute with an 8-point bump in ejection fraction, an effect present even at modest 0.7 mM ketone levels. Acute oral dosing in cardiogenic shock (Berg-Hansen 2023) and a 14-day trial (Berg-Hansen 2024) extended the hemodynamic finding. The caveat is real: every trial is small (n=8 to 24), short, surrogate-endpoint, and concentrated in one research program with no hard-outcome data yet. This is clinical territory, not a self-directed use.
Recovery / Repair: 6.0/10
Score: 6.0/10This is the strongest exercise-context signal. Poffe 2019 randomized 18 athletes through a 3-week training-overload block and found ketone ester sustained about 15 percent higher week-3 training load, blunted overreaching symptoms, and roughly halved the stress marker GDF15 versus control. A follow-up, Poffe 2023, raised serum EPO about 26 percent and capillary contacts 44 percent. Glycogen-resynthesis data are mixed (Holdsworth 2017 positive, Vandoorne 2017 null), and a muscle-damage trial, Martin-Arrowsmith 2020, found no recovery benefit. Real but cluster-specific.
Metabolic Health: 5.5/10
Score: 5.5/10Exogenous ketones produce genuine acute metabolic effects. Myette-Cote 2018 found a ketone ester before an oral glucose load lowered glucose area-under-curve about 17 percent in 20 healthy adults. Stubbs 2018 showed a ketone drink suppressed the hunger hormone ghrelin and subjective appetite for hours versus a sugar drink in 15 people. Both are small, single-dose, acute studies, so they support a transient appetite or glucose blunting tool, not durable weight loss or glycemic control. Treat as an acute lever, not a metabolic therapy.
Blood Sugar / Glycemic Control: 5.5/10
Score: 5.5/10A ketone ester acutely lowers blood glucose. Myette-Cote 2018 reported a roughly 17 percent reduction in glucose area-under-curve after an oral glucose tolerance test in 20 healthy adults when ketones were taken first, an effect mediated by suppressed liver glucose output and free fatty acids. The effect is real and fast but acute only: there is no evidence that exogenous ketones improve standing fasting glucose, HbA1c, or insulin sensitivity over weeks, and no multi-week glycemic-control trial exists. Treat it as a single-meal lever for blunting a glucose spike, not a substitute for diet, exercise, or glucose-lowering medication. People on insulin or sulfonylureas should be cautious about additive glucose lowering, and people with type 1 diabetes should know exogenous ketones confound the ketone readings used to flag ketoacidosis.
Energy / Fatigue: 5.0/10
Score: 5.0/10Mixed and individual. Some users report a clean acute energy and focus lift from the rapid fuel shift, since the brain and muscle readily use BHB as a substrate; others feel GI-driven fatigue or sluggishness, especially with salt forms that add a sodium and mineral load. The effect is acute and clears within hours, so it is not a substitute for sleep, food, or training adaptation, and there is no accumulating energy benefit from daily use. The supporting evidence is the acute-fuel and appetite literature (Stubbs 2018) rather than any dedicated energy or fatigue trial, so this sits right at the midpoint: a real but short-lived and highly person-dependent shift, best confirmed by self-testing one dose against a clear task.
| Use Case | Score | Summary |
|---|---|---|
| ○ Endurance / Cardio Primary | 4.0 | Exogenous ketones do NOT reliably improve endurance performance. The definitive meta-analysis, Brooks 2022, pooled 8 studies and 80 participants and found no significant effect (Hedges g=0.14, 95% CI -0.20 to 0.47, p=0.42). The single positive cyclist study, Cox 2016, came from the patent-holding Oxford lab and rested on a time-trial sub-study of only 8 athletes. A separate trial in elite cyclists, Leckey 2017, found ketone diester actually impaired performance about 2 percent with GI distress. The score sits below the midpoint because the marketed core use is the weakest part of the evidence base. |
| ○ Cognition / Focus | 4.5 | The cognitive case is widely overstated. Acute effects in healthy adults are small and mostly appear under fatigue: Evans 2018 found a ketone ester attenuated executive-function decline only after exhausting exercise. The famous Alzheimer's and mild-cognitive-impairment evidence people cite is almost entirely from medium-chain triglycerides or ketogenic diets (Fortier 2021, Henderson 2009), NOT from ketone esters. There are essentially no exogenous-ester cognition RCTs in dementia. The mechanism (brain ketone uptake bypassing impaired glucose metabolism) is plausible but unproven for this supplement form. |
| ○ Geriatric / Aging Population | 4.5 | The cardiac and brain-fuel mechanisms are most interesting in older adults, and the heart-failure work (Nielsen 2019) involves an older population, but this remains clinical and investigational rather than a general geriatric supplement. |
| ○ Neuroprotection | 4.0 | Plausible mechanism, thin direct evidence. The brain readily uses ketones as fuel, and the ketogenic diet has a real anticonvulsant track record (Neal 2008: 38 percent of children achieved over 50 percent seizure reduction versus 6 percent on control). But that is the diet, not exogenous ketones. Human anticonvulsant or neuroprotective data for ketone supplements themselves is essentially preclinical. Do not credit the supplement with the diet's record. |
| ○ Body Composition / Fat Loss | 4.0 | Weak. Acute appetite suppression (Stubbs 2018) is a plausible lever, but no trial shows exogenous ketones drive meaningful fat loss. They add calories and cost, and ketosis from a supplement does not equal fat oxidation. A ketogenic diet, not a ketone drink, is what changes body composition. |
| ○ Anti-Inflammatory | 4.0 | BHB inhibits the NLRP3 inflammasome in preclinical models, a real and interesting mechanism, but human anti-inflammatory outcome data for exogenous ketones is sparse. Mechanism outpaces clinical proof. |
| ○ Mitochondrial | 4.0 | Ketones are an efficient mitochondrial fuel and may improve cardiac energetics (Nielsen 2019), but human mitochondrial-function endpoints outside the failing heart are not established. |
| ○ Hormonal / Endocrine | 4.0 | Exogenous ketones have acute endocrine effects, notably ghrelin suppression (Stubbs 2018) and modest shifts in insulin and glucagon, but they are not an endocrine therapy. People with type 1 diabetes must be especially cautious, since exogenous ketones can complicate the interpretation of blood ketone readings used to detect ketoacidosis. The hormonal effects are transient and not a basis for treating any endocrine condition. |
| ○ VO2 Max | 3.5 | No evidence exogenous ketones raise VO2 max. The performance meta-analysis (Brooks 2022) found no aerobic-capacity benefit, and one trial showed impairment. |
| ○ Flow State / Peak Mental Performance | 3.5 | Anecdotal focus reports exist, but no flow-state or peak-performance RCT evidence for the supplement form. |
| ○ Strength / Power | 3.0 | Not a strength or power aid. No meaningful human data supports use for resistance performance; ketones are an endurance-fuel concept, not an anabolic one. |
| ○ Longevity / Lifespan | 3.0 | Animal lifespan data on ketogenic states exist, but there is no human longevity evidence for exogenous ketones, and the acute-only pharmacology makes a durable aging effect unlikely from intermittent dosing. |
| ○ Mood / Emotional Regulation | 3.0 | No direct mood RCT base for exogenous ketones. Any benefit is indirect via energy or focus. |
| ○ Sleep Quality | 3.0 | No dedicated sleep evidence; the Leuven overload protocol used a pre-sleep dose for recovery, not for sleep quality itself. |
| ○ Traumatic Brain Injury | 3.0 | Alternative brain fuel is a plausible mechanism after injury, but human exogenous-ketone TBI data is preclinical or absent. |
Frequently Asked Questions
Do exogenous ketones actually improve endurance performance?
Mostly no. The definitive meta-analysis, Brooks 2022, pooled 8 studies and 80 participants and found no significant endurance benefit (Hedges g=0.14, p=0.42). The one famous positive study, Cox 2016, rested on just 8 cyclists and came from the patent-holding lab, while Leckey 2017 found ketones impaired elite cyclists about 2 percent with GI distress. Use them for training-overload tolerance, not raw speed.
What are exogenous ketones and how do they work?
Exogenous ketones are supplements that raise blood beta-hydroxybutyrate (BHB) to roughly 1 to 5 mM within 30 to 60 minutes, without any change in diet. They come in three forms: the ketone monoester (strongest, harshest taste), ketone salts (BHB bound to sodium or other minerals, cheaper but dose-capped), and 1,3-butanediol (a precursor metabolized to BHB). BHB then acts as both an alternative fuel for muscle, heart, and brain and a signaling molecule.
How much should I take and when?
A typical acute dose is 10 to 25 g of BHB from a ketone ester, or 7 to 12 g from salts, taken 30 to 60 minutes before the target task. There is no established standing daily protocol for healthy people because the effect is acute and clears within about 4 hours per Clarke 2012. The training-overload protocol from Poffe 2019 used about 25 g post-exercise plus a pre-sleep dose during a heavy block.
Can exogenous ketones help heart failure?
There is a genuine but early signal. Nielsen 2019 gave acute 3-hydroxybutyrate to 16 heart-failure patients and saw cardiac output rise about 2.0 L per minute and ejection fraction climb 8 points. Follow-ups extended this to cardiogenic shock and a 14-day trial. But every study is small (n=8 to 24), short, surrogate-endpoint, and from one research group, with no hard-outcome trials yet. This is investigational, clinician-supervised territory, not a self-directed use.
Do exogenous ketones help with Alzheimer's or brain fog?
The brain-benefit claim is largely overstated for the supplement. Most of the encouraging dementia evidence comes from medium-chain triglycerides or ketogenic diets (Fortier 2021, Henderson 2009), not from ketone esters. Acute cognitive effects in healthy adults are small and mostly show up only under fatigue (Evans 2018). The mechanism is plausible but exogenous-ester cognition RCTs in dementia essentially do not exist yet.
Are exogenous ketones safe and what are the side effects?
At normal doses they are intrinsically safe, with no catastrophic signal. A 28-day study, Soto-Mota 2019, found no adverse effect on blood, urine, or physical parameters. The main issue is tolerability: esters taste bad and cause nausea or diarrhea at higher doses, while salts add a meaningful sodium and mineral load that limits the dose and can drive GI distress. 1,3-butanediol is processed by the same enzymes as alcohol and can feel mildly intoxicating.
Ketone ester vs ketone salts: which should I choose?
The ester is the strongest and most studied form, raising ketones reliably into the 1 to 5 mM range, but it tastes harsh and costs about $1 per gram, so a performance dose runs around $30. Salts are cheaper and more palatable but the bound sodium, calcium, or magnesium caps how much BHB you can take and causes more GI distress per gram. If you want the effect studied in trials, use the ester; if cost and taste matter more than potency, salts are the budget option.
How fast do exogenous ketones work and how long do they last?
Fast on, fast off. Blood ketones peak about 30 to 60 minutes after a dose and clear by roughly 4 hours, with a BHB half-life of 0.8 to 3.1 hours per Clarke 2012. A single dose produces no lasting adaptation, which is why durability is the weakest part of the profile. Any benefit must be timed to the task you care about, and there is no accumulating effect from taking them daily.
What could change Exogenous Ketones's score?
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
The most plausible upward move would come from positive hard-outcome data in heart failure: if the small hemodynamic trials (Nielsen et al. 2019, Berg-Hansen et al. 2024) mature into a larger trial showing reduced hospitalizations or mortality, Efficacy and Evidence would rise first and pull the score into strong-recommend territory for that population. The most plausible downward move is a confirmatory null in the recovery literature, which would weaken the one strong exercise use. Cost coming down would help value but not the core evidence.
| Scenario | Dimension shifts | New Score |
|---|---|---|
| A large heart-failure outcome trial confirms hard-endpoint benefit | Efficacy 2.6 to 3.8, Evidence 2.8 to 3.8 | 7.2 / 10 💪 Strong recommend |
| A second independent lab replicates the training-overload tolerance effect | Efficacy 2.6 to 3.2, Evidence 2.8 to 3.3, Bioindividuality 2.8 to 3.2 | 6.7 / 10 👍 Worth trying |
| Ester cost falls roughly fivefold (manufacturing scale) | Cost 4.3 to 2.5 | 6.5 / 10 👍 Worth trying |
| A well-powered exogenous-ketone cognition RCT in MCI shows real benefit | Efficacy 2.6 to 3.2, Breadth 3.0 to 3.6, Evidence 2.8 to 3.3 | 6.9 / 10 👍 Worth trying |
| A new recovery meta-analysis returns null, undercutting the best use | Efficacy 2.6 to 2.0, Evidence 2.8 to 2.4 | 5.2 / 10 ⚖️ Neutral |
| A specific, demonstrated long-term harm signal emerges at chronic high doses | Safety 1.8 to 3.0, Side effects 2.8 to 3.4 | 4.6 / 10 ⚖️ Neutral |
Key Evidence Sources
- Brooks E et al. 2022 - Acute Ingestion of Ketone Monoesters and Precursors Do Not Enhance Endurance Exercise Performance: A Systematic Review and Meta-Analysis, International Journal of Sport Nutrition and Exercise Metabolism. 8 studies, 80 participants; Hedges g=0.14 (95% CI -0.20 to 0.47), p=0.42; no endurance benefit
- Cox PJ et al. 2016 - Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes, Cell Metabolism. 39 athletes across sub-studies; the positive time-trial arm was only n=8; from the patent-holding Oxford lab
- Leckey JJ et al. 2017 - Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists, Frontiers in Physiology. n=10 elite cyclists; performance impaired about 2 percent with GI distress
- Evans M, Egan B 2018 - Intermittent Running and Cognitive Performance after Ketone Ester Ingestion, Medicine & Science in Sports & Exercise. n=11; run-to-exhaustion not different (p=0.126); executive function preserved under fatigue
- Poffe C et al. 2019 - Ketone ester supplementation blunts overreaching symptoms during endurance training overload, The Journal of Physiology. n=18; about 15 percent higher week-3 training load; GDF15 roughly halved
- Poffe C et al. 2023 - Ketone ester supplementation raises serum erythropoietin and increases muscle capillarization, The Journal of Physiology. n=18; serum EPO up about 26 percent; capillary contacts up 44 percent
- Holdsworth DA et al. 2017 - A Ketone Ester Drink Increases Postexercise Muscle Glycogen Synthesis, Medicine & Science in Sports & Exercise. n=12; muscle glycogen about 50 percent higher with ketone ester plus glucose
- Vandoorne T et al. 2017 - Intake of a Ketone Ester Drink during Recovery from Exercise Promotes mTORC1 Signaling, Frontiers in Physiology. n=8; raised mTORC1 signaling but did NOT increase glycogen, contradicting Holdsworth
- Martin-Arrowsmith PW et al. 2020 - Ketone Monoester Supplementation Does Not Expedite Recovery from Muscle Damage, Frontiers in Nutrition. n=20; no benefit for eccentric muscle-damage recovery
- Nielsen R et al. 2019 - Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients, Circulation. n=16 HFrEF; cardiac output up about 2.0 L per minute; LVEF up 8 points; benefit at 0.7 mM
- Berg-Hansen K et al. 2023 - Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock, JACC: Heart Failure. n=12; acute oral ketone ester augmented cardiac output; LVEF up about 4 points (p=0.005)
- Berg-Hansen K et al. 2024 - Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure, Circulation. n=24 HFrEF; 14-day oral ketone ester; resting cardiac output up, NT-proBNP down about 18 percent
- Myette-Cote E et al. 2018 - Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test, The Journal of Physiology. n=20 healthy; glucose AUC lowered about 17 percent (p=0.001)
- Stubbs BJ et al. 2018 - A Ketone Ester Drink Lowers Human Ghrelin and Appetite, Obesity. n=15; ketone drink suppressed ghrelin and hunger 1.5 to 4 hours versus dextrose
- Clarke K et al. 2012 - Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects, Regulatory Toxicology and Pharmacology. n=54; BHB half-life 0.8 to 3.1 hours; well tolerated; GI effects only at the highest doses
- Soto-Mota A et al. 2019 - Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults, Regulatory Toxicology and Pharmacology. 28-day safety; no adverse effect on blood, urine, or physical parameters
- Neal EG et al. 2008 - The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial, Lancet Neurology. n=145; 38 percent achieved over 50 percent seizure reduction versus 6 percent on control; DIET not exogenous ketones
- Fortier M et al. 2021 - A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT, Alzheimer's & Dementia. n=83 MCI; MCT ketogenic drink improved recall, fluency, naming; MCT not ketone ester
- Henderson ST et al. 2009 - Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease, Nutrition & Metabolism. n=152 AD; caprylic-acid (MCT) triglyceride improved ADAS-Cog 3.36 points in APOE4-negative subjects only; MCT not ketone ester
What does the evidence say about Exogenous Ketones?
Evidence on this intervention is summarized across three complementary streams: contemporary clinical research, pre-RCT-era pharmacology and observational use, and the traditional medical systems that documented it first. Convergence across streams signals higher confidence; divergence is surfaced honestly.
Modern Clinical Research
Confidence: Medium
Citations: Brooks 2022, Nielsen 2019, Poffe 2019, Myette-Cote 2018, Stubbs 2018, Soto-Mota 2019
Traditional Medicine Systems
Confidence: Limited
Citations: Neal 2008
Holistic Evidence for Exogenous Ketones
The lenses agree on one point and diverge on another. Ketosis as a metabolic state has a real, century-long therapeutic history (epilepsy) and modern clinical promise (heart failure), but exogenous ketone supplements are a new, acute-only way to reach that state and have not yet earned the diet's track record, and they clearly fail to deliver the endurance benefit they are most often sold for.
What to Track If You Try This
These are the data points that matter most while running a 30-day Experiment with this intervention.
How to read this section
- Pre
- Test or score before starting the protocol. Anchors a baseline.
- During
- Track while running the protocol so you can see if anything is changing.
- Post
- Re-test after a full cycle to confirm the change held.
- Up
- The marker should rise. For most positive outcomes, that is a good sign.
- Down
- The marker should fall. For most positive outcomes, that is a good sign.
- Stable
- The marker should hold steady. Big swings in either direction are a yellow flag.
- Watch
- Direction depends on dose, timing, and your baseline. Pay close attention to the trend.
- N/A
- No expected direction. The entry is there to anchor a baseline reading.
- Primary
- The Pulse dimension most likely to shift. Track this first.
- Secondary
- Also relevant, but a smaller or less consistent shift. Track if Primary is unclear.
Bloodwork to Order
Open These Markers In Your Dashboard
- Blood Ketones During | Expected Up
- Blood Glucose During | Expected Down
- Sodium During | Expected Watch
Pulse Dimensions to Watch
- Energy During | Expected Watch | Secondary
- Body During | Expected Watch | Primary
Subjective Signals (Daily Voice Card)
- GI comfort after dosing Scale 1-5 | During | Expected Watch
- Perceived effort during the target task Scale 1-5 | During | Expected Watch
Red Flags: Stop and Consult
- Persistent diarrhea, vomiting, or severe nausea after dosing
- Lightheadedness or low blood sugar symptoms, especially if you take glucose-lowering medication
- Using ketone salts at high frequency if you have hypertension or sodium-sensitive kidney disease
📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. Tier bands: Skip 0–2.9, Caution 3.0–4.4, Neutral 4.5–5.7, Worth Trying 5.8–6.9, Strong Recommend 7.0–8.7, Top-tier 8.8–10.0.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 1.800 − 1.096 = 0.704
Formula v2.0 maps EV = 0 to score 5.0. Above neutral, EV = +4.00 reaches 10.0; below neutral, EV = −5.36 reaches 0.0. Both sides use the full 5-point half-scale.
Score = 5 + (0.704 / 4.00) × 5 = 5.9 / 10
